123 related articles for article (PubMed ID: 32996039)
21. In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations.
Kohajda Z; Virág L; Hornyik T; Husti Z; Sztojkov-Ivanov A; Nagy N; Horváth A; Varga R; Prorok J; Szlovák J; Tóth N; Gazdag P; Topal L; Naveed M; Árpádffy-Lovas T; Pászti B; Magyar T; Koncz I; Déri S; Demeter-Haludka V; Aigner Z; Ördög B; Patfalusi M; Tálosi L; Tiszlavicz L; Földesi I; Jost N; Baczkó I; Varró A
Br J Pharmacol; 2022 Jul; 179(13):3382-3402. PubMed ID: 35106755
[TBL] [Abstract][Full Text] [Related]
22. QT as a predictor of recurrence after atrial fibrillation ablation and the impact of amiodarone: results from the placebo-controlled AMIO-CAT trial.
Diederichsen SZ; Darkner S; Chen X; Johannessen A; Pehrson S; Hansen J; Svendsen JH
Europace; 2019 Jul; 21(7):1055-1062. PubMed ID: 30843038
[TBL] [Abstract][Full Text] [Related]
23. Effect of ranolazine on ventricular repolarization in class III antiarrhythmic drug-treated rabbits.
Frommeyer G; Kaiser D; Uphaus T; Kaese S; Osada N; Rajamani S; Belardinelli L; Breithardt G; Eckardt L; Milberg P
Heart Rhythm; 2012 Dec; 9(12):2051-8. PubMed ID: 23044390
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
Kirchhof P; Degen H; Franz MR; Eckardt L; Fabritz L; Milberg P; Läer S; Neumann J; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2003 Apr; 305(1):257-63. PubMed ID: 12649377
[TBL] [Abstract][Full Text] [Related]
25. Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation.
Wolfes J; Ellermann C; Broer N; Rath B; Willy K; Leitz PR; Lange PS; Eckardt L; Frommeyer G
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33092020
[TBL] [Abstract][Full Text] [Related]
26. Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Sicouri S; Pourrier M; Gibson JK; Lynch JJ; Antzelevitch C
Heart Rhythm; 2012 Mar; 9(3):422-9. PubMed ID: 22019863
[TBL] [Abstract][Full Text] [Related]
27. Effects of dofetilide and ranolazine on atrial fibrillatory rate in a horse model of acutely induced atrial fibrillation.
Carstensen H; Hesselkilde EZ; Haugaard MM; Flethøj M; Carlson J; Pehrson S; Jespersen T; Platonov PG; Buhl R
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):596-606. PubMed ID: 30661267
[TBL] [Abstract][Full Text] [Related]
28. Influences of rapid pacing-induced electrical remodeling on pharmacological manipulation of the atrial refractoriness in rabbits.
Chiba T; Kondo N; Takahara A
J Pharmacol Sci; 2016 Mar; 130(3):170-6. PubMed ID: 27032905
[TBL] [Abstract][Full Text] [Related]
29. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
30. Potent and reversible effects of ATI-2001 on atrial and atrioventricular nodal electrophysiological properties in guinea pig isolated perfused heart.
Raatikainen MJ; Morey TE; Druzgala P; Milner P; Gonzalez MD; Dennis DM
J Pharmacol Exp Ther; 2000 Nov; 295(2):779-85. PubMed ID: 11046118
[TBL] [Abstract][Full Text] [Related]
31. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
32. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
[TBL] [Abstract][Full Text] [Related]
33. Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs.
Platou ES; Refsum H
J Cardiovasc Pharmacol; 1982; 4(5):839-46. PubMed ID: 6182417
[TBL] [Abstract][Full Text] [Related]
34. Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.
Wirth KJ; Paehler T; Rosenstein B; Knobloch K; Maier T; Frenzel J; Brendel J; Busch AE; Bleich M
Cardiovasc Res; 2003 Nov; 60(2):298-306. PubMed ID: 14613859
[TBL] [Abstract][Full Text] [Related]
35. Hybrid therapy of atrial fibrillation.
Santini M; Pignalberi C; Ricci R; Calò L
Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814
[TBL] [Abstract][Full Text] [Related]
36. Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure.
He Z; Sun C; Xu Y; Cheng D
Biomed Pharmacother; 2016 Dec; 84():1760-1767. PubMed ID: 27847200
[TBL] [Abstract][Full Text] [Related]
37. Effective suppression of atrial fibrillation by the antihistaminic agent antazoline: First experimental insights into a novel antiarrhythmic agent.
Frommeyer G; Sterneberg M; Dechering DG; Kaese S; Bögeholz N; Pott C; Fehr M; Bogossian H; Milberg P; Eckardt L
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039911
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of dofetilide, amiodarone, and class lc drugs on left and right atrial refractoriness and left atrial vulnerability in pigs.
Wirth KJ; Knobloch K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):166-74. PubMed ID: 11218069
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiologic Effects of the New Class III Antiarrhythmic Drug Dofetilide in an Experimental Canine Model of Pacing-induced Atrial Fibrillation.
Feld GK; Cha Y
J Cardiovasc Pharmacol Ther; 1997 Jul; 2(3):195-203. PubMed ID: 10684458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
